Canada>Canada http://pattonandcooke.com/?page=120 atorvastatin tablet  The FDA has recently approved a phase II pivotal trial for the DigniCap, a cap worn during chemotherapy that circulates coolant through its inner layer, reducing the delivery of toxins to the hair follicle. In a small pilot study, the device allowed most women with early-stage breast cancer receiving chemotherapy to preserve the majority of their hair. "Most breast cancer research is focused on prevention and treatment, as it should be," says Hope S. Rugo, MD, lead investigator of the trial and director of the breast oncology and clinical trials education at UCSF. "But if we can enhance patients' quality of life, too, that's a good thing."